Portfolio company
Reticular
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops interpretable artificial intelligence models for embryo genetic screening and drug discovery to assist prospective parents and pharmaceutical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genomic Prediction
The company develops genetic screening tests for IVF embryos to assess disease risks for fertility clinics and prospective parents.
Future Fertility
This company develops artificial intelligence software for oocyte quality assessment to assist fertility clinics and patients with reproductive treatment decisions.
Imvitro
Imvitro develops an artificial intelligence platform for embryo selection to help fertility clinics improve success rates and transparency for IVF patients.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
DreamFold
This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.
DreamFold AI
This company develops generative artificial intelligence models for protein design to discover medicines for pharmaceutical and biotechnology researchers.
eye2gene
Eye2Gene develops an AI-powered platform that analyses retinal imaging to accelerate genetic diagnosis of inherited diseases for pharmaceutical companies and eye care professionals.
Lucid Genomics
This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.
